Long Non-coding RNA ZFAS1 Correlates with Clinical Progression and Prognosis in Cancer Patients

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Oct 6

PMID 28977885

Citations 14

Authors

Fangteng Liu

Hui Gao

Siyu Li

Xiaolin Ni

Zhengming Zhu

Affiliations

Soon will be listed here.

Abstract

Dysregulation of long non-coding RNA zinc finger antisense 1 (ZFAS1) has been reported in many types of cancers. We performed a synthetic analysis to clarify its prognostic significance as a cancer molecular-marker. Several databases (including PubMed, Web of Science, Embase together with Wanfang and China National Knowledge Internet database) were retrieved to identify ZFAS1-related articles. A total of eight articles were included in this meta-analysis. Hazard ratios (HR) and 95% confidence intervals (CI) were applied to assess the association between ZFAS1 expression level and overall survival (OS). Odds ratios (OR) were calculated with RevMan 5.3 software to determine the relationship between ZFAS1 expression and clinicopathologic features. The pooled results of the meta-analysis indicated that high ZFAS1 expression level was positively correlated with poor OS (HR = 1.87, 95% CI: 1.38-2.36, p< 0.001) in human solid cancers. The statistical significance was also observed in subgroup analysis stratified by the cancer type, analysis method, sample size and follow-up time. Furthermore, the elevated ZFAS1 expression was significantly related to positive lymph node metastasis (OR = 4.18, 95% CI: 2.70-6.48, p< 0.001). The present results suggest that ZFAS1 might be served as a novel promising biomarker for prognosis in Chinese patients with solid cancers.

Citing Articles

Biological roles of SLC16A1-AS1 lncRNA and its clinical impacts in tumors.

Liao B, Wang J, Yuan Y, Luo H, Ouyang X Cancer Cell Int. 2024; 24(1):122.

PMID: 38555465 PMC: 10981830. DOI: 10.1186/s12935-024-03285-6.

Potential of long non-coding RNAs as a therapeutic target and molecular markers in glioblastoma pathogenesis.

Chaudhary R Heliyon. 2021; 7(3):e06502.

PMID: 33786397 PMC: 7988331. DOI: 10.1016/j.heliyon.2021.e06502.

Editing and Chemical Modifications on Non-Coding RNAs in Cancer: A New Tale with Clinical Significance.

Torsin L, Petrescu G, Sabo A, Chen B, Brehar F, Dragomir M Int J Mol Sci. 2021; 22(2).

PMID: 33430133 PMC: 7827606. DOI: 10.3390/ijms22020581.

The Long Non-coding RNA ZFAS1 Sponges miR-193a-3p to Modulate Hepatoblastoma Growth by Targeting RALY via HGF/c-Met Pathway.

Cui X, Wang Z, Liu L, Liu X, Zhang D, Li J Front Cell Dev Biol. 2019; 7:271.

PMID: 31781561 PMC: 6856658. DOI: 10.3389/fcell.2019.00271.

Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis.

Li Z, Qin X, Bian W, Li Y, Shan B, Yao Z J Exp Clin Cancer Res. 2019; 38(1):477.

PMID: 31775815 PMC: 6882153. DOI: 10.1186/s13046-019-1473-8.

References

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Liu Y, Zheng L, Wang Q, Hu Y . Emerging roles and mechanisms of long noncoding RNAs in atherosclerosis. Int J Cardiol. 2016; 228:570-582. DOI: 10.1016/j.ijcard.2016.11.182. View

Tian F, Meng F, Wang X . Overexpression of long-noncoding RNA ZFAS1 decreases survival in human NSCLC patients. Eur Rev Med Pharmacol Sci. 2017; 20(24):5126-5131. View

Mattick J . The genetic signatures of noncoding RNAs. PLoS Genet. 2009; 5(4):e1000459. PMC: 2667263. DOI: 10.1371/journal.pgen.1000459. View

Ma C, Shi X, Zhu Q, Li Q, Liu Y, Yao Y . The growth arrest-specific transcript 5 (GAS5): a pivotal tumor suppressor long noncoding RNA in human cancers. Tumour Biol. 2015; 37(2):1437-44. DOI: 10.1007/s13277-015-4521-9. View

Lavorgna G, Vago R, Sarmini M, Montorsi F, Salonia A, Bellone M . Long non-coding RNAs as novel therapeutic targets in cancer. Pharmacol Res. 2016; 110:131-138. DOI: 10.1016/j.phrs.2016.05.018. View

Liu R, Zeng Y, Zhou C, Wang Y, Li X, Liu Z . Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients. Sci Rep. 2017; 7(1):18. PMC: 5428368. DOI: 10.1038/s41598-017-00050-w. View

Li Z, Shen J, Chan M, Wu W . TUG1: a pivotal oncogenic long non-coding RNA of human cancers. Cell Prolif. 2016; 49(4):471-5. PMC: 6496395. DOI: 10.1111/cpr.12269. View

Thorenoor N, Faltejskova-Vychytilova P, Hombach S, Mlcochova J, Kretz M, Svoboda M . Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer. Oncotarget. 2015; 7(1):622-37. PMC: 4808022. DOI: 10.18632/oncotarget.5807. View

10.

Li J, Tian H, Yang J, Gong Z . Long Noncoding RNAs Regulate Cell Growth, Proliferation, and Apoptosis. DNA Cell Biol. 2016; 35(9):459-70. DOI: 10.1089/dna.2015.3187. View

11.

Gao K, Ji Z, She K, Yang Q, Shao L . Long non-coding RNA ZFAS1 is an unfavourable prognostic factor and promotes glioma cell progression by activation of the Notch signaling pathway. Biomed Pharmacother. 2017; 87:555-560. DOI: 10.1016/j.biopha.2017.01.014. View

12.

Jiang C, Li X, Zhao H, Liu H . Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis. Mol Cancer. 2016; 15(1):62. PMC: 5043609. DOI: 10.1186/s12943-016-0545-z. View

13.

Tano K, Akimitsu N . Long non-coding RNAs in cancer progression. Front Genet. 2012; 3:219. PMC: 3479403. DOI: 10.3389/fgene.2012.00219. View

14.

Askarian-Amiri M, Crawford J, French J, Smart C, Smith M, Clark M . SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA. 2011; 17(5):878-91. PMC: 3078737. DOI: 10.1261/rna.2528811. View

15.

Liu F, Pan H, Xia G, Qiu C, Zhu Z . Prognostic and clinicopathological significance of long noncoding RNA H19 overexpression in human solid tumors: evidence from a meta-analysis. Oncotarget. 2016; 7(50):83177-83186. PMC: 5347760. DOI: 10.18632/oncotarget.13076. View

16.

Lian Y, Cai Z, Gong H, Xue S, Wu D, Wang K . HOTTIP: a critical oncogenic long non-coding RNA in human cancers. Mol Biosyst. 2016; 12(11):3247-3253. DOI: 10.1039/c6mb00475j. View

17.

Fang C, Zan J, Yue B, Liu C, He C, Yan D . Long non-coding ribonucleic acid zinc finger antisense 1 promotes the progression of colonic cancer by modulating ZEB1 expression. J Gastroenterol Hepatol. 2016; 32(6):1204-1211. DOI: 10.1111/jgh.13646. View

18.

Hogeveen M, Blom H, den Heijer M . Maternal homocysteine and small-for-gestational-age offspring: systematic review and meta-analysis. Am J Clin Nutr. 2011; 95(1):130-6. DOI: 10.3945/ajcn.111.016212. View

19.

Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z . Amplification of Long Noncoding RNA ZFAS1 Promotes Metastasis in Hepatocellular Carcinoma. Cancer Res. 2015; 75(15):3181-91. DOI: 10.1158/0008-5472.CAN-14-3721. View

20.

Deniz E, Erman B . Long noncoding RNA (lincRNA), a new paradigm in gene expression control. Funct Integr Genomics. 2016; 17(2-3):135-143. DOI: 10.1007/s10142-016-0524-x. View